Critics demand stop to 'Guinea pig' sepsis clinical trial

September 26, 2018

(HealthDay)—A major non-profit advocacy group is asking that a large government trial comparing treatments for sepsis be shut down.

The trial, called Clovers, "places seriously ill patients at risk without the possibility of gaining information that can provide benefits either to the subjects or to future patients," according to an analysis of the trial by investigators at the U.S. National Institutes of Health Clinical Center in Bethesda, Md. And in a letter sent to the federal Office for Human Research Protection, Public Citizen compared the study to "an experiment that would be conducted on laboratory animals," The New York Times reported.

"The human subjects of the Clovers trial, as designed and currently conducted, are unwitting guinea pigs in a physiology experiment," Public Citizens' Michael Carome, M.D., and Sidney Wolfe, M.D., wrote in their letter. The Clovers trial began in March and is funded by the NIH. It is moving forward and hopes to enroll 2,320 patients from 44 hospitals nationwide.

The Clovers trial seeks to determine which one of two therapeutic options—limiting fluids and starting vasopressors, or adding and holding off on drug therapy—works best to curb .

Explore further: Clinical trial fails to disclose risk of death, repeat heart attacks, advocacy group says

More information: The New York Times Article
Clovers Clinical Trial

Related Stories

Clinical trial fails to disclose risk of death, repeat heart attacks, advocacy group says

August 2, 2017
A clinical trial testing blood transfusion therapies for heart attack patients may place participants in danger of death or a repeat heart attack without fully disclosing those risks, a Washington, D.C.-based consumer advocacy ...

Most parents willing to enroll child in food allergen trials

April 4, 2018
(HealthDay)—The majority of caregivers of children with food allergy are willing to consider participation in clinical trials for food allergy immunotherapy, according to a research letter published in the March issue of ...

Patients' genes could hold the clue to reducing severe sepsis

August 1, 2016
Patients' genes could unlock urgently needed new treatments for severe sepsis, which kills three and a half times as many Australians as the road toll.

Early identification and treatment of septic shock to save lives

June 1, 2012
(Medical Xpress) -- Recognition of severe septic shock early and starting a patient on an effective antibiotic treatment immediately is critical to saving lives, according to an editorial by two Virginia Commonwealth University ...

University was tipped off to possible unauthorized trials of herpes vaccine

December 5, 2017
The university that employed a controversial herpes vaccine researcher has told the federal government it learned last summer of the possibility of his illegal experimentation on human subjects. But Southern Illinois University ...

Recommended for you

Small-scale poultry farming could mean big problem in developing countries

December 16, 2018
Small-scale farming in developing countries provides those in rural communities with income and access to protein, but it may have a large impact on antibiotic resistance, according to a new University of Michigan study.

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.